Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

CTR Enrichment Series: Melanocortin 3 Receptor and Pediatric Obesity

For Providers
Monday, February 3, 2020

12:00 PM - 1:00 PM
Main Hospital, 6th Floor, M7607 Conference Room
111 Michigan Ave NW
Washington, District Of Columbia, 20010
Get Directions

Add to Calendar 03-02-2020 12:00:00 03-02-2020 13:00:00 15

Jack A. Yanovski, M.D., Ph.D., has carried out a series of clinical studies related to the evaluation and treatment of obesity in children and adults. Learn more from Dr. Yanovski at this event hosted by the Center for Translational Research.

Jack A. Yanovski, M.D., Ph.D., is chief of the Section on Growth and Obesity in the Program on Developmental Endocrinology and Genetics. Dr. Yanovski has carried out a series of clinical studies related to the evaluation and treatment of overweight and obesity in children and adults, as well as laboratory investigations of the molecular etiologies of obesity. His randomized controlled trials have elucidated the limitations of current pharmacotherapeutic approaches for treatment of pediatric obesity and his observational studies have demonstrated the importance of disinhibited eating behaviors for pediatric obesity. His lab has also elucidated the roles of the melanocortin 3 receptor and brain-derived neurotrophic factor in human body weight regulation. Read more about Dr. Yanovski. Main Hospital, 6th Floor, M7607 Conference Room false DD/MM/YYYY

Jack A. Yanovski, M.D., Ph.D., is chief of the Section on Growth and Obesity in the Program on Developmental Endocrinology and Genetics. Dr. Yanovski has carried out a series of clinical studies related to the evaluation and treatment of overweight and obesity in children and adults, as well as laboratory investigations of the molecular etiologies of obesity. His randomized controlled trials have elucidated the limitations of current pharmacotherapeutic approaches for treatment of pediatric obesity and his observational studies have demonstrated the importance of disinhibited eating behaviors for pediatric obesity. His lab has also elucidated the roles of the melanocortin 3 receptor and brain-derived neurotrophic factor in human body weight regulation. Read more about Dr. Yanovski.